Search results
Μπορείτε να λάβετε βεβαίωση αρνητικού αποτελέσματος σε διαγνωστικό ελέγχο κορωνοϊού COVID-19. Η βεβαίωση μπορεί να εκδοθεί για διαγνωστικούς ελέγχους (PCR ή Rapid Test) που κάνατε μέχρι και ένα μήνα ...
- Get a Certificate of a Negative Covid-19 Diagnos
You can get a certificate of a negative COVID-19 test...
- E.Ψ.Π
Public sector's organizations, whose online services are...
- Get a Certificate of a Negative Covid-19 Diagnos
COVID-19 rapid antigen tests or RAT s, also frequently called COVID-19 lateral flow tests or LFT s, are rapid antigen tests used to detect SARS-CoV-2 infection (COVID-19). They are quick to implement with minimal training, cost a fraction of other forms of COVID-19 testing, and give users a result within 5–30 minutes.
Szybkie testy diagnostyczne to nowoczesne, wygodne i precyzyjne sposoby na wykrywanie szerokiej gamy zakażeń, pozostałości alergenów czy mykotoksyn, a także obecności narkotyków.
Antigen tests are rapid tests that usually produce results in 15-30 minutes. Positive results are accurate and reliable. However, in general, antigen tests are less likely to detect the virus than PCR tests are, especially if you don’t have symptoms. Therefore, a single negative antigen test cannot rule out infection.
The ID NOW™ Platform is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW™ isothermal nucleic acid amplification technology (NAAT) provides molecular results in just minutes, allowing you to make effective clinical decisions sooner. Contact Sales.
flexible testing. FLEXIBLE WORKFLOW. ID NOW™ COVID-19 2.0 detects SARS-CoV-2 in 6‑12 minutes with the option to add on an ID NOW Influenza A & B 2 test without collecting another sample.
4 maj 2020 · The ID NOW COVID-19 test is a rapid, molecular point-of-care test that detects COVID-19 in 13 minutes or less. It is used on our ID NOW platform. Abbott received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the ID NOW COVID-19 test in March 2020.
